New Releases from NCBI BookshelfVenetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable.​Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable.